Elso Orlando G, Bivona Augusto E, Sanchez Alberti Andrés, Cerny Natacha, Fabian Lucas, Morales Celina, Catalán César A N, Malchiodi Emilio L, Cazorla Silvia I, Sülsen Valeria P
Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), CONICET-Universidad de Buenos Aires, Junín 956 2° floor, Buenos Aires 1113, Argentina.
Cátedra de Farmacognosia, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956 2° floor, Buenos Aires 1113, Argentina.
Molecules. 2020 Apr 25;25(9):2014. doi: 10.3390/molecules25092014.
The sesquiterpene lactones eupatoriopicrin, estafietin, eupahakonenin B and minimolide have been isolated from Argentinean Astearaceae species and have been found to be active against epimastigotes. The aim of this work was to evaluate the activity of these compounds by analyzing their effect against the stages of the parasites that are infective for the human. Even more interesting, we aimed to determine the effect of the most active and selective compound on an model of infection. Eupatoriopicrin was the most active against amastigotes and tripomastigotes (IC = 2.3 µg/mL, and 7.2 µg/mL, respectively) and displayed a high selectivity index. This compound was selected to study on an model of infection. The administration of 1 mg/kg/day of eupatoriopicrin for five consecutive days to infected mice produced a significant reduction in the parasitaemia levels in comparison with non-treated animals (area under parasitaemia curves 4.48 vs. 30.47, respectively). Skeletal muscular tissues from eupatopicrin-treated mice displayed only focal and interstitial lymphocyte inflammatory infiltrates and small areas of necrotic; by contrast, skeletal tissues from infected mice treated with the vehicle showed severe lymphocyte inflammatory infiltrates with necrosis of the adjacent myocytes. The results indicate that eupatoriopicrin could be considered a promising candidate for the development of new therapeutic agents for Chagas disease.
倍半萜内酯类化合物泽兰苦内酯、紫茎泽兰素、紫茎泽兰宁B和小苦内酯已从阿根廷菊科植物中分离出来,并被发现对锥鞭毛体具有活性。这项工作的目的是通过分析这些化合物对人体感染性寄生虫阶段的影响来评估其活性。更有趣的是,我们旨在确定最具活性和选择性的化合物对感染模型的影响。泽兰苦内酯对无鞭毛体和锥鞭毛体的活性最高(IC分别为2.3μg/mL和7.2μg/mL),并显示出高选择性指数。选择该化合物用于感染模型的研究。与未治疗的动物相比,连续五天给感染小鼠每天注射1mg/kg的泽兰苦内酯,可使寄生虫血症水平显著降低(寄生虫血症曲线下面积分别为4.48和30.47)。用泽兰苦内酯治疗的小鼠的骨骼肌组织仅显示局灶性和间质性淋巴细胞炎性浸润以及小面积坏死;相比之下,用赋形剂治疗的感染小鼠的骨骼肌组织显示严重的淋巴细胞炎性浸润以及相邻肌细胞坏死。结果表明,泽兰苦内酯可被认为是开发治疗恰加斯病新治疗药物的有前途的候选物。